2020
DOI: 10.1007/s12035-020-01894-6
|View full text |Cite
|
Sign up to set email alerts
|

Genetic Ablation of Hematopoietic Cell Kinase Accelerates Alzheimer’s Disease–Like Neuropathology in Tg2576 Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 63 publications
0
7
0
Order By: Relevance
“…It has been reported that hematopoietic microglia can ameliorate the progression of AD by eliminating amyloid deposition through cell-specific phagocytic mechanisms ( Lampron et al, 2011 ). Furthermore, hematopoietic cells and their associated factors have potential therapeutic value in AD, and the downregulation of the relative number of hematopoietic cells may be one of the critical theories ( Sanchez-Ramos et al, 2008 ; Lim et al, 2020 ).…”
Section: Resultsmentioning
confidence: 99%
“…It has been reported that hematopoietic microglia can ameliorate the progression of AD by eliminating amyloid deposition through cell-specific phagocytic mechanisms ( Lampron et al, 2011 ). Furthermore, hematopoietic cells and their associated factors have potential therapeutic value in AD, and the downregulation of the relative number of hematopoietic cells may be one of the critical theories ( Sanchez-Ramos et al, 2008 ; Lim et al, 2020 ).…”
Section: Resultsmentioning
confidence: 99%
“…Similarly, the results of phagocytosis and platelet activation of these proteins were also reported. Studies have shown that Hck deficiency weakens the phagocytic function of microglia a β ( Lim et al., 2020 ). Hck is one of the key regulators of phagocytosis among the Src family tyrosine kinases (SFKs) in myeloid cells and combined absence of the Src family kinases Hck drastically impairs phagocytosis ( Lim et al., 2018 ; Lőrincz et al., 2019 ).…”
Section: Discussionmentioning
confidence: 99%
“…Considering that activation of tyrosine kinases is a critical signaling step in various processes essential for immune cell function, including proliferation and inflammatory responses, it is reasonable to conjecture that alteration of SFK activity by toxic amyloid species might be involved in the AD neurodegenerative process. This premise is corroborated using complementary genetic [121,129–131] and pharmacological [43,88,124,132] approaches, suggesting that modulating the activation of SFKs affects pathology in animal models of AD.…”
Section: Sfks Microglia and Neurodegenerationmentioning
confidence: 89%